Clinical Trial: Pilot Study of Hydroxychloroquine for the Treatment of AIMSS

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07825454) titled 'Pilot Study of Hydroxychloroquine for the Treatment of AIMSS' on Aug. 25.

Brief Summary: The purpose of this study is to evaluate the effectiveness of hydroxychloroquine sulfate (a type of drug commonly used to treat joint pain caused by inflammation, swelling) in reducing joint pain associated with Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) for patients with breast cancer.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) Joint Pain Breast Cancer

Intervention: DRUG: Hydroxychloroquine Sulfate (HCQ)

Drug: Hydroxychloroquine...